Progress in Preclinical Research on Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Bronchopulmonary Dysplasia
American Journal of Perinatology · 01.05.2026 · 43 (07) · 863-868
DOI: 10.1055/a-2704-7823 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Perinatology, erschienen am 01.05.2026. Verfasst von Shimeng Zhao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, P. R. China. Hauptthemen laut MEDLINE: Bronchopulmonary Dysplasia, Exosomes, Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation. Die Arbeit nennt 82 Literaturangaben. Gefördert von: Liaoning Science and Technology Program.
Abstract (Originalsprache)
Bronchopulmonary dysplasia (BPD) is the most common chronic respiratory disease in premature infants and affects their survival rate and quality of life. There are no reliable interventions for the prevention or treatment of BPD, but the emergence of mesenchymal stem cell (MSC) therapies has brought new hope. Research has shown that paracrine may be the therapeutic mechanism of action underlying physiological improvements in the lungs of BPD patients treated with MSC therapy. The therapeutic vector in the MSC secretome comprises exosomes with low immunogenicity and stability, and that can easily cross the blood-brain barrier. In the future, exosomes may become the preferred treatment for BPD in clinical settings. Here, we review the progress of preclinical research on the use of MSC-derived exosomes as a promising treatment option for BPD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Neonatology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, P. R. China.
- Department of Neonatology, The Fifth Affiliated Hospital of Zunyi Medical University, Zhuhai, Guangzhou, P. R. China.
Förderung
- Liaoning Science and Technology Program
Zitieren
APA
Zhao, S., & Han, S. (2026). Progress in Preclinical Research on Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Bronchopulmonary Dysplasia. American Journal of Perinatology, 43(07), 863-868. https://doi.org/10.1055/a-2704-7823
Vancouver
Zhao S, Han S. Progress in Preclinical Research on Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Bronchopulmonary Dysplasia. American Journal of Perinatology. 2026;43(07):863-868. doi:10.1055/a-2704-7823
BibTeX
@article{Zhao2026,
author = {Zhao, Shimeng and Han, Shuang},
title = {Progress in Preclinical Research on Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Bronchopulmonary Dysplasia},
journal = {American Journal of Perinatology},
year = {2026},
volume = {43},
number = {07},
pages = {863--868},
doi = {10.1055/a-2704-7823}
}
EUVIMED